BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Lowering of health loss ratio to normalised levels is a big positive realised in Q2 FY22 for ICICI Lombard General Insurance Company Ltd. as the impact of Covid-19 subsided.
However, rising claims of non-Covid cases, continued weak motor registrations and absence of rate hikes in motor limit any quick recovery expectations for ICICI Lombard in FY22.
As such, we await a cyclical recovery. Non-underwriting results remain healthy and will continue to support overall profits, true to the high investment leverage business of multiline insurers.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
